Sulfonylurea [EPC]

Sulfonylurea [EPC] was reported 123130 times

Drugs of the Sulfonylurea [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 HYPOGLYCAEMIC ENCEPHALOPATHY 72 0.1851
1 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 154 0.1450
2 NEPHROGENIC ANAEMIA 589 0.1270
3 HYPERPARATHYROIDISM SECONDARY 292 0.1164
4 HYPOGLYCAEMIC COMA 335 0.1161
5 EARLY SATIETY 177 0.0909
6 BLOOD GLUCOSE DECREASED 4317 0.0898
7 DIABETIC NEUROPATHY 429 0.0866
8 HYPOGLYCAEMIA 4197 0.0864
9 BLADDER TRANSITIONAL CELL CARCINOMA 119 0.0830
10 GLYCOSYLATED HAEMOGLOBIN INCREASED 1923 0.0761
11 DIABETES MELLITUS INADEQUATE CONTROL 1343 0.0758
12 BLOOD GLUCOSE FLUCTUATION 822 0.0749
13 REBOUND ACID HYPERSECRETION 225 0.0743
14 GASTROINTESTINAL HYPOMOTILITY 166 0.0736
15 ISCHAEMIC CARDIOMYOPATHY 207 0.0674
16 BLOOD GLUCOSE INCREASED 12630 0.0670
17 GLYCOSYLATED HAEMOGLOBIN DECREASED 97 0.0602
18 DIABETIC METABOLIC DECOMPENSATION 82 0.0590
19 ESSENTIAL HYPERTENSION 106 0.0579
20 DIABETIC RETINOPATHY 195 0.0574
21 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 68 0.0568
22 PANCREATIC CARCINOMA METASTATIC 158 0.0555
23 ADENOCARCINOMA PANCREAS 70 0.0545
24 END STAGE RENAL DISEASE 994 0.0544
25 DIABETIC NEPHROPATHY 116 0.0527
26 IMPAIRED GASTRIC EMPTYING 682 0.0500
27 BLOOD GLUCOSE ABNORMAL 881 0.0476
28 HEART INJURY 114 0.0458
29 HYPOGLYCAEMIC UNCONSCIOUSNESS 86 0.0434
30 HAEMORRHAGIC ANAEMIA 187 0.0425
31 COLONIC POLYP 70 0.0423
32 INJECTION SITE NODULE 460 0.0418
33 CORONARY ARTERY DISEASE 1259 0.0415
34 MEDICATION RESIDUE 107 0.0415
35 HYPERTENSIVE HEART DISEASE 76 0.0406
36 DIABETIC COMPLICATION 96 0.0377
37 CHRONIC KIDNEY DISEASE 2826 0.0372
38 CAROTID ARTERY STENOSIS 129 0.0369
39 ARTERIOSCLEROSIS CORONARY ARTERY 242 0.0365
40 RENAL FAILURE CHRONIC 277 0.0360
41 LACTIC ACIDOSIS 1162 0.0358
42 EUGLYCAEMIC DIABETIC KETOACIDOSIS 147 0.0356
43 PERIPHERAL VASCULAR DISORDER 182 0.0353
44 STOMACH DISCOMFORT 175 0.0338
45 DIABETIC COMA 94 0.0335
46 HYPERLIPIDAEMIA 386 0.0323
47 PANCREATITIS CHRONIC 76 0.0321
48 CORONARY ARTERY STENOSIS 159 0.0316
49 VENTRICULAR HYPERTROPHY 78 0.0311
50 CARDIAC FAILURE CONGESTIVE 2493 0.0310
51 ORAL INTAKE REDUCED 75 0.0310
52 ORTHOPNOEA 96 0.0301
53 THERAPEUTIC AGENT TOXICITY 100 0.0300
54 HYPERGLYCAEMIA 1083 0.0297
55 ANOREXIA 381 0.0295
56 ANGINA UNSTABLE 188 0.0289
57 ARTERIOSCLEROSIS 272 0.0289
58 DIASTOLIC DYSFUNCTION 89 0.0288
59 RENAL INJURY 856 0.0288
60 DIABETIC FOOT 88 0.0287
61 MYOCARDIAL ISCHAEMIA 323 0.0284
62 RENAL FAILURE ACUTE 1182 0.0278
63 DIABETES MELLITUS 2092 0.0274
64 ERUCTATION 529 0.0273
65 HIGH DENSITY LIPOPROTEIN DECREASED 90 0.0270
66 DIABETIC KETOACIDOSIS 643 0.0267
67 CORONARY ARTERY OCCLUSION 358 0.0261
68 TYPE 2 DIABETES MELLITUS 873 0.0259
69 PANCREATITIS ACUTE 574 0.0255
70 AORTIC STENOSIS 88 0.0252
71 DIVERTICULUM INTESTINAL 109 0.0249
72 INJECTION SITE EXTRAVASATION 304 0.0246
73 LEFT VENTRICULAR HYPERTROPHY 104 0.0243
74 RENAL FAILURE 3202 0.0241
75 BENIGN PROSTATIC HYPERPLASIA 124 0.0240
76 MULTIPLE INJURIES 150 0.0238
77 INTENTIONAL DEVICE MISUSE 104 0.0236
78 BUNDLE BRANCH BLOCK LEFT 99 0.0233
79 CARDIOMEGALY 287 0.0233
80 DIFFICULTY IN WALKING 80 0.0232
81 TYPE 1 DIABETES MELLITUS 140 0.0232
82 TOE AMPUTATION 117 0.0230
83 HYPERKALAEMIA 805 0.0229
84 MITRAL VALVE INCOMPETENCE 255 0.0225
85 RENAL CYST 178 0.0224
86 ECONOMIC PROBLEM 339 0.0223
87 AZOTAEMIA 89 0.0223
88 RENAL TUBULAR NECROSIS 218 0.0222
89 CAROTID ARTERY OCCLUSION 81 0.0222
90 TRICUSPID VALVE INCOMPETENCE 175 0.0220
91 DIVERTICULUM 156 0.0219
92 LOWER GASTROINTESTINAL HAEMORRHAGE 162 0.0219
93 BLOOD POTASSIUM INCREASED 353 0.0217
94 PHARYNGOLARYNGEAL PAIN 115 0.0216
95 PANCREATIC DISORDER 105 0.0213
96 PANCREATITIS 1109 0.0210
97 DYSLIPIDAEMIA 106 0.0208
98 ACUTE CORONARY SYNDROME 172 0.0207
99 ATRIOVENTRICULAR BLOCK FIRST DEGREE 90 0.0207
100 ACUTE KIDNEY INJURY 3172 0.0207
101 BLOOD UREA INCREASED 347 0.0207
102 NEPHROPATHY 192 0.0205
103 SPINAL COLUMN STENOSIS 97 0.0205
104 HEPATIC NEOPLASM 67 0.0205
105 SUSPECTED SUICIDE 96 0.0205
106 WEIGHT DECREASED 5710 0.0204
107 ARTERIAL OCCLUSIVE DISEASE 160 0.0203
108 ACUTE MYOCARDIAL INFARCTION 595 0.0202
109 HYPERKERATOSIS 111 0.0201
110 FEELING JITTERY 383 0.0201
111 ATELECTASIS 190 0.0196
112 KETOACIDOSIS 147 0.0196
113 MENTAL STATUS CHANGES 540 0.0194
114 PROSTATOMEGALY 76 0.0193
115 BLOOD TRIGLYCERIDES INCREASED 337 0.0191
116 AORTIC VALVE INCOMPETENCE 81 0.0190
117 PSYCHOLOGICAL TRAUMA 164 0.0190
118 MEDICATION RESIDUE PRESENT 89 0.0186
119 GOITRE 76 0.0185
120 HUNGER 258 0.0185
121 LEG AMPUTATION 76 0.0184
122 GOUT 330 0.0184
123 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 75 0.0184
124 UPPER GASTROINTESTINAL HAEMORRHAGE 309 0.0183
125 TUBULOINTERSTITIAL NEPHRITIS 344 0.0183
126 ABNORMAL LOSS OF WEIGHT 125 0.0183
127 METABOLIC ACIDOSIS 586 0.0183
128 CEREBRAL ATROPHY 72 0.0180
129 SLEEP APNOEA SYNDROME 344 0.0180
130 BODY HEIGHT DECREASED 191 0.0178
131 HAEMATOCRIT DECREASED 354 0.0178
132 VITAMIN B12 DEFICIENCY 72 0.0178
133 HYPOVOLAEMIA 104 0.0178
134 GANGRENE 107 0.0177
135 LIPASE INCREASED 136 0.0177
136 HAIR DISORDER 146 0.0177
137 CARDIAC MURMUR 153 0.0177
138 BUNDLE BRANCH BLOCK RIGHT 81 0.0176
139 VISUAL DISTURBANCE 101 0.0176
140 IRON DEFICIENCY ANAEMIA 161 0.0174
141 SPINAL OSTEOARTHRITIS 153 0.0174
142 DECREASED APPETITE 4039 0.0174
143 CARDIAC VALVE DISEASE 99 0.0173
144 CARDIAC PACEMAKER INSERTION 103 0.0173
145 POLYDIPSIA 68 0.0172
146 CATARACT OPERATION 102 0.0172
147 CARDIOMYOPATHY 254 0.0172
148 ABSCESS LIMB 73 0.0171
149 BLOOD CHOLESTEROL ABNORMAL 79 0.0171
150 FAILURE TO THRIVE 88 0.0169
151 ATRIOVENTRICULAR BLOCK COMPLETE 113 0.0169
152 ABDOMINAL HERNIA 77 0.0169
153 WEIGHT FLUCTUATION 176 0.0168
154 MYOCARDIAL INFARCTION 2933 0.0168
155 HAEMODIALYSIS 141 0.0168
156 STENT PLACEMENT 135 0.0167
157 PROTHROMBIN TIME PROLONGED 100 0.0167
158 MACULAR OEDEMA 93 0.0166
159 NOCTURIA 201 0.0165
160 INTERVERTEBRAL DISC DEGENERATION 153 0.0165
161 BLOOD PRESSURE INADEQUATELY CONTROLLED 99 0.0164
162 HEPATIC STEATOSIS 306 0.0164
163 CONGESTIVE CARDIOMYOPATHY 68 0.0163
164 ELECTROCARDIOGRAM ABNORMAL 128 0.0163
165 TRANSIENT ISCHAEMIC ATTACK 547 0.0162
166 BLOOD MAGNESIUM DECREASED 139 0.0161
167 ATRIAL FLUTTER 128 0.0160
168 PEMPHIGOID 121 0.0160
169 BLOOD PRESSURE SYSTOLIC INCREASED 312 0.0160
170 OLIGURIA 99 0.0159
171 CARDIAC FAILURE ACUTE 106 0.0159
172 URINE OUTPUT DECREASED 139 0.0159
173 ACUTE RESPIRATORY FAILURE 305 0.0158
174 OEDEMA PERIPHERAL 1924 0.0158
175 BLADDER CANCER 929 0.0158
176 RHINITIS ALLERGIC 70 0.0157
177 OBESITY 250 0.0157
178 DECUBITUS ULCER 127 0.0156
179 ACIDOSIS 119 0.0156
180 BLOOD LACTIC ACID INCREASED 82 0.0156
181 DYSPEPSIA 1529 0.0155
182 ESCHERICHIA URINARY TRACT INFECTION 66 0.0155
183 PROTEIN URINE PRESENT 77 0.0154
184 ENERGY INCREASED 91 0.0154
185 INJECTION SITE HAEMORRHAGE 1228 0.0154
186 CHOLELITHIASIS 503 0.0153
187 INJECTION SITE MASS 565 0.0153
188 LEFT VENTRICULAR DYSFUNCTION 102 0.0152
189 GASTROINTESTINAL HAEMORRHAGE 1266 0.0151
190 ANGINA PECTORIS 434 0.0151
191 ANHEDONIA 397 0.0151
192 DEHYDRATION 2005 0.0150
193 POLLAKIURIA 626 0.0150
194 FLATULENCE 843 0.0149
195 CORONARY ARTERIAL STENT INSERTION 75 0.0148
196 CORONARY ARTERY BYPASS 85 0.0148
197 POLYURIA 121 0.0148
198 INTERNATIONAL NORMALISED RATIO INCREASED 420 0.0147
199 VENTRICULAR TACHYCARDIA 241 0.0146
200 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 761 0.0146
201 BLOOD CREATININE INCREASED 952 0.0146
202 HAIR COLOUR CHANGES 181 0.0145
203 HAEMORRHOIDAL HAEMORRHAGE 71 0.0145
204 LUNG INFILTRATION 128 0.0145
205 ATRIOVENTRICULAR BLOCK 112 0.0145
206 GASTRITIS EROSIVE 67 0.0144
207 HEPATIC CIRRHOSIS 270 0.0144
208 ISCHAEMIA 66 0.0143
209 ATRIAL FIBRILLATION 1397 0.0143
210 COLD SWEAT 252 0.0143
211 GASTROOESOPHAGEAL REFLUX DISEASE 1148 0.0142
212 RENAL DISORDER 663 0.0142
213 LOCALISED INFECTION 344 0.0142
214 VULVOVAGINAL PRURITUS 72 0.0142
215 GLOMERULAR FILTRATION RATE DECREASED 174 0.0141
216 CELLULITIS 713 0.0141
217 UNRESPONSIVE TO STIMULI 365 0.0141
218 DRUG EFFECT DECREASED 758 0.0141
219 MULTI-ORGAN FAILURE 243 0.0140
220 HEPATOMEGALY 138 0.0140
221 HYPOMAGNESAEMIA 195 0.0140
222 EYE HAEMORRHAGE 186 0.0139
223 BLOOD CHOLESTEROL INCREASED 647 0.0139
224 HYPERCHOLESTEROLAEMIA 134 0.0139
225 VENTRICULAR EXTRASYSTOLES 144 0.0139
226 OSTEOMYELITIS 250 0.0138
227 CATARACT 821 0.0138
228 OVERWEIGHT 74 0.0138
229 SKIN ULCER 356 0.0138
230 DYSPNOEA EXERTIONAL 517 0.0137
231 HYPERTRIGLYCERIDAEMIA 80 0.0137
232 FUNGAL INFECTION 455 0.0136
233 VENTRICULAR FIBRILLATION 151 0.0136
234 RENAL IMPAIRMENT 1142 0.0136
235 HYPOPHAGIA 347 0.0136
236 LEUKOCYTOSIS 245 0.0135
237 DIALYSIS 192 0.0135
238 FAECAL INCONTINENCE 65 0.0135
239 ACCIDENTAL UNDERDOSE 194 0.0135
240 FLUID OVERLOAD 196 0.0135
241 UROSEPSIS 124 0.0134
242 FLUID RETENTION 683 0.0134
243 LARGE INTESTINE POLYP 93 0.0134
244 DYSURIA 492 0.0134
245 COAGULOPATHY 222 0.0133
246 INTERNAL HAEMORRHAGE 152 0.0133
247 INCREASED APPETITE 252 0.0132
248 HAEMORRHOIDS 257 0.0132
249 HAEMATURIA 449 0.0131
250 INCREASED UPPER AIRWAY SECRETION 67 0.0130
251 HYPOTHERMIA 132 0.0130
252 BODY TEMPERATURE DECREASED 128 0.0130
253 BLOOD SODIUM DECREASED 245 0.0130
254 GASTRITIS 340 0.0129
255 FLANK PAIN 121 0.0129
256 HIATUS HERNIA 167 0.0129
257 CHOLECYSTITIS 153 0.0128
258 BLINDNESS TRANSIENT 94 0.0127
259 AMMONIA INCREASED 65 0.0127
260 PULMONARY HYPERTENSION 265 0.0127
261 HAEMORRHAGIC STROKE 99 0.0127
262 VISUAL ACUITY REDUCED 421 0.0127
263 DUODENAL ULCER 89 0.0126
264 ROTATOR CUFF SYNDROME 162 0.0126
265 BLOOD PRESSURE DIASTOLIC DECREASED 92 0.0125
266 HAIR TEXTURE ABNORMAL 166 0.0124
267 NEPHROLITHIASIS 569 0.0124
268 REFUSAL OF TREATMENT BY PATIENT 81 0.0124
269 PHARMACEUTICAL PRODUCT COMPLAINT 322 0.0124
270 ILEUS 154 0.0124
271 CONSTIPATION 2696 0.0123
272 CEREBROVASCULAR ACCIDENT 2079 0.0123
273 BLOOD POTASSIUM DECREASED 369 0.0123
274 EXOSTOSIS 112 0.0123
275 HEMIPLEGIA 102 0.0122
276 LACERATION 115 0.0122
277 RALES 71 0.0122
278 CARPAL TUNNEL SYNDROME 171 0.0122
279 INABILITY TO AFFORD MEDICATION 121 0.0122
280 RHABDOMYOLYSIS 507 0.0121
281 MADAROSIS 141 0.0121
282 BLOOD URINE PRESENT 230 0.0121
283 BLOOD ALBUMIN DECREASED 96 0.0121
284 ABDOMINAL DISTENSION 1256 0.0120
285 RIGHT VENTRICULAR FAILURE 84 0.0120
286 SINUS TACHYCARDIA 170 0.0120
287 GASTRIC ULCER HAEMORRHAGE 66 0.0119
288 HEART RATE IRREGULAR 269 0.0119
289 CARDIOVASCULAR DISORDER 302 0.0119
290 INTERVERTEBRAL DISC PROTRUSION 260 0.0119
291 HYPERHIDROSIS 1529 0.0119
292 FEAR 319 0.0118
293 HICCUPS 97 0.0118
294 URINARY INCONTINENCE 350 0.0118
295 PULMONARY OEDEMA 529 0.0118
296 GASTROENTERITIS 172 0.0118
297 SPLENOMEGALY 138 0.0118
298 BLOOD URIC ACID INCREASED 68 0.0118
299 EJECTION FRACTION DECREASED 183 0.0118
300 BACK INJURY 128 0.0118
301 HYPERCHLORHYDRIA 69 0.0117
302 MALNUTRITION 131 0.0117
303 CEREBRAL INFARCTION 286 0.0117
304 RECTAL HAEMORRHAGE 501 0.0116
305 GALLBLADDER DISORDER 208 0.0116
306 CHOLECYSTITIS ACUTE 66 0.0116
307 LIMB INJURY 316 0.0116
308 ASTHENIA 4349 0.0116
309 HYPERVENTILATION 67 0.0115
310 MICTURITION URGENCY 132 0.0115
311 BLOOD TESTOSTERONE DECREASED 79 0.0115
312 BLOOD IRON DECREASED 137 0.0115
313 PROSTATIC SPECIFIC ANTIGEN INCREASED 159 0.0115
314 OSTEOARTHRITIS 489 0.0115
315 PRURITUS GENERALISED 249 0.0115
316 SUPRAVENTRICULAR TACHYCARDIA 110 0.0115
317 TOOTH ABSCESS 117 0.0115
318 PLEURAL EFFUSION 699 0.0115
319 INJECTION SITE IRRITATION 146 0.0115
320 MUSCLE STRAIN 99 0.0114
321 RETINAL HAEMORRHAGE 81 0.0114
322 ERECTILE DYSFUNCTION 292 0.0114
323 THIRST 203 0.0114
324 COMPLETED SUICIDE 943 0.0113
325 CARDIAC FLUTTER 73 0.0113
326 BACK DISORDER 183 0.0112
327 ECCHYMOSIS 77 0.0112
328 NAUSEA 8882 0.0112
329 INJECTION SITE BRUISING 893 0.0112
330 RENAL PAIN 118 0.0111
331 INCOHERENT 72 0.0111
332 TREMOR 1846 0.0111
333 RIB FRACTURE 228 0.0111
334 SCIATICA 176 0.0110
335 CHEST PAIN 2044 0.0110
336 PULMONARY MASS 164 0.0110
337 HEARING IMPAIRED 66 0.0110
338 JOINT INJURY 235 0.0110
339 PAROSMIA 83 0.0110
340 CYSTITIS 350 0.0110
341 URINARY TRACT INFECTION 1870 0.0110
342 LOCAL SWELLING 191 0.0109
343 OEDEMA 593 0.0109
344 TOOTH INFECTION 144 0.0109
345 HAEMOGLOBIN DECREASED 1121 0.0109
346 GLAUCOMA 210 0.0109
347 RED BLOOD CELL COUNT DECREASED 311 0.0109
348 CARDIAC DISORDER 1016 0.0108
349 MUSCULOSKELETAL CHEST PAIN 168 0.0108
350 ANAEMIA 2070 0.0108
351 ABASIA 268 0.0108
352 ELECTROLYTE IMBALANCE 126 0.0108
353 POLYP 71 0.0108
354 RETCHING 231 0.0108
355 MEDICATION ERROR 600 0.0108
356 FAECES DISCOLOURED 234 0.0108
357 NERVOUSNESS 563 0.0108
358 PULMONARY CONGESTION 142 0.0108
359 BRONCHITIS 796 0.0107
360 DIARRHOEA 6928 0.0107
361 ORAL PAIN 240 0.0107
362 TORSADE DE POINTES 84 0.0107
363 HYPOXIA 377 0.0107
364 PANCREATIC CARCINOMA 309 0.0107
365 ANURIA 92 0.0107
366 WEIGHT INCREASED 2373 0.0106
367 DYSSTASIA 309 0.0106
368 DISORIENTATION 419 0.0106
369 SHOCK 242 0.0105
370 NERVE COMPRESSION 97 0.0105
371 HEMIPARESIS 178 0.0105
372 NODULE 137 0.0105
373 SLUGGISHNESS 107 0.0105
374 HYPERTENSION 2221 0.0105
375 ISCHAEMIC STROKE 187 0.0105
376 CARDIAC OPERATION 90 0.0105
377 FALL 3484 0.0105
378 LIGAMENT SPRAIN 103 0.0104
379 MAJOR DEPRESSION 76 0.0104
380 ABDOMINAL PAIN UPPER 2141 0.0104
381 SKIN LACERATION 113 0.0104
382 DECREASED ACTIVITY 112 0.0104
383 WRONG DRUG ADMINISTERED 92 0.0103
384 FULL BLOOD COUNT DECREASED 208 0.0103
385 DRUG INTERACTION 1634 0.0103
386 METASTASES TO LIVER 181 0.0103
387 HYPERSOMNIA 294 0.0102
388 DYSARTHRIA 386 0.0102
389 INCONTINENCE 108 0.0102
390 DIVERTICULITIS 283 0.0102
391 EMPHYSEMA 103 0.0102
392 MYOPATHY 88 0.0102
393 GENERALISED OEDEMA 126 0.0102
394 RESPIRATORY FAILURE 741 0.0102
395 HYPERTHYROIDISM 147 0.0101
396 POST-TRAUMATIC STRESS DISORDER 68 0.0101
397 DIZZINESS 5052 0.0101
398 AORTIC ANEURYSM 77 0.0101
399 BRADYCARDIA 535 0.0101
400 VITREOUS FLOATERS 99 0.0101
401 BLINDNESS UNILATERAL 142 0.0101
402 DRUG TOXICITY 137 0.0100
403 BLOOD PRESSURE INCREASED 1537 0.0100
404 GASTRIC ULCER 191 0.0100
405 MACULAR DEGENERATION 120 0.0100
406 DRUG DISPENSING ERROR 153 0.0100
407 INCREASED TENDENCY TO BRUISE 92 0.0100
408 UPPER LIMB FRACTURE 199 0.0100
409 ACTIVITIES OF DAILY LIVING IMPAIRED 197 0.0099
410 LOW DENSITY LIPOPROTEIN INCREASED 77 0.0099
411 VITAMIN D DEFICIENCY 97 0.0099
412 TREATMENT NONCOMPLIANCE 543 0.0099
413 HOSPICE CARE 98 0.0099
414 POSTOPERATIVE WOUND INFECTION 67 0.0099
415 NEOPLASM 114 0.0099
416 DYSGEUSIA 734 0.0099
417 ORTHOSTATIC HYPOTENSION 172 0.0099
418 VOMITING 4640 0.0099
419 WHITE BLOOD CELL COUNT INCREASED 378 0.0098
420 NEUROPATHY PERIPHERAL 937 0.0098
421 DRUG DOSE OMISSION 1628 0.0098
422 CARDIAC ARREST 810 0.0098
423 FEELING COLD 273 0.0098
424 DIZZINESS POSTURAL 95 0.0098
425 CHROMATURIA 221 0.0098
426 ARRHYTHMIA 463 0.0098
427 LETHARGY 562 0.0098
428 CONFUSIONAL STATE 1575 0.0097
429 EXTRASYSTOLES 68 0.0097
430 THYROID DISORDER 150 0.0097
431 HYPOKALAEMIA 449 0.0097
432 ARTHROPOD BITE 72 0.0097
433 MASS 135 0.0096
434 PERICARDIAL EFFUSION 223 0.0096
435 SYNCOPE 963 0.0096
436 NERVE INJURY 107 0.0096
437 AGEUSIA 240 0.0096
438 VISION BLURRED 1317 0.0096
439 HYPOTHYROIDISM 306 0.0096
440 EATING DISORDER 204 0.0096
441 ARTHRITIS 753 0.0096
442 HEART RATE DECREASED 336 0.0096
443 BLADDER DISORDER 95 0.0096
444 BIPOLAR DISORDER 104 0.0096
445 SENSORY LOSS 77 0.0096
446 ANAL INCONTINENCE 86 0.0096
447 FEELING DRUNK 71 0.0095
448 PRESYNCOPE 232 0.0095
449 SEASONAL ALLERGY 135 0.0095
450 FLUSHING 969 0.0095
451 KIDNEY INFECTION 187 0.0095
452 COLON CANCER 142 0.0095
453 WRONG TECHNIQUE IN DRUG USAGE PROCESS 346 0.0095
454 SEPSIS 1061 0.0095
455 EPISTAXIS 710 0.0095
456 LOSS OF CONSCIOUSNESS 1216 0.0095
457 HYDRONEPHROSIS 71 0.0095
458 CARDIOGENIC SHOCK 136 0.0095
459 BLOOD CALCIUM DECREASED 106 0.0094
460 SMALL INTESTINAL OBSTRUCTION 116 0.0094
461 MUSCULOSKELETAL DISCOMFORT 162 0.0094
462 BOWEL MOVEMENT IRREGULARITY 72 0.0094
463 INJURY 658 0.0094
464 BACK PAIN 2174 0.0093
465 HEART RATE INCREASED 924 0.0093
466 INJECTION SITE DISCOMFORT 98 0.0093
467 DRUG LEVEL INCREASED 154 0.0093
468 CARDIO-RESPIRATORY ARREST 389 0.0093
469 HYPOTENSION 1862 0.0093
470 SPUTUM DISCOLOURED 88 0.0093
471 BONE DISORDER 169 0.0093
472 GASTROENTERITIS VIRAL 167 0.0092
473 PERIPHERAL COLDNESS 127 0.0092
474 MUSCULOSKELETAL PAIN 484 0.0092
475 HAEMORRHAGE INTRACRANIAL 138 0.0092
476 BLOOD CREATINE PHOSPHOKINASE INCREASED 264 0.0092
477 BALANCE DISORDER 790 0.0091
478 TENDERNESS 95 0.0091
479 ANKLE FRACTURE 141 0.0091
480 PROTEINURIA 173 0.0091
481 OSTEOPENIA 138 0.0091
482 CARDIAC FAILURE 730 0.0091
483 PAIN IN EXTREMITY 2678 0.0091
484 FURUNCLE 72 0.0091
485 FOOT FRACTURE 172 0.0091
486 TOOTH FRACTURE 100 0.0091
487 UNDERDOSE 662 0.0091
488 MUSCULAR WEAKNESS 1030 0.0091
489 DRY MOUTH 735 0.0090
490 GAIT DISTURBANCE 1729 0.0090
491 INJECTION SITE HAEMATOMA 131 0.0090
492 RESPIRATORY RATE INCREASED 80 0.0090
493 HAEMOPTYSIS 251 0.0090
494 PRODUCT DOSE OMISSION 586 0.0090
495 STAPHYLOCOCCAL INFECTION 296 0.0090
496 ABDOMINAL DISCOMFORT 1505 0.0090
497 TOXIC EPIDERMAL NECROLYSIS 136 0.0089
498 CHOLECYSTECTOMY 102 0.0089
499 WOUND INFECTION 97 0.0088
500 PHARYNGEAL OEDEMA 136 0.0088
501 HAEMATEMESIS 224 0.0088
502 UPPER RESPIRATORY TRACT INFECTION 407 0.0088
503 SUBDURAL HAEMATOMA 126 0.0088
504 RESTLESS LEGS SYNDROME 160 0.0088
505 SINUS BRADYCARDIA 85 0.0088
506 HEAD INJURY 278 0.0088
507 MELAENA 193 0.0088
508 GROIN PAIN 77 0.0088
509 MUSCLE ATROPHY 111 0.0088
510 FEELING HOT 536 0.0087
511 METASTASES TO LUNG 101 0.0087
512 HAEMATOMA 226 0.0087
513 HYPONATRAEMIA 491 0.0087
514 RHINORRHOEA 563 0.0087
515 HAEMOLYTIC ANAEMIA 78 0.0087
516 SINUS DISORDER 172 0.0087
517 TROPONIN INCREASED 66 0.0087
518 MULTIPLE ALLERGIES 68 0.0087
519 PYELONEPHRITIS 75 0.0086
520 ACCIDENTAL OVERDOSE 316 0.0086
521 RESPIRATORY TRACT CONGESTION 137 0.0086
522 DYSPNOEA 4880 0.0086
523 PERIPHERAL SWELLING 1326 0.0086
524 TACHYPNOEA 117 0.0086
525 BLISTER 481 0.0086
526 NECK PAIN 478 0.0085
527 POST PROCEDURAL COMPLICATION 164 0.0085
528 BASAL CELL CARCINOMA 133 0.0085
529 PNEUMONIA 2755 0.0085
530 HYPOACUSIS 366 0.0085
531 CONTUSION 818 0.0085
532 HALLUCINATION, VISUAL 179 0.0085
533 HEPATIC ENCEPHALOPATHY 79 0.0085
534 RASH PRURITIC 458 0.0084
535 ALTERED STATE OF CONSCIOUSNESS 183 0.0084
536 ASCITES 248 0.0084
537 ABDOMINAL PAIN 1953 0.0084
538 EAR PAIN 163 0.0084
539 BLOOD PRESSURE DECREASED 557 0.0084
540 RETINAL DETACHMENT 77 0.0084
541 ORAL CANDIDIASIS 110 0.0083
542 SCRATCH 88 0.0083
543 DYSPHONIA 486 0.0083
544 CLOSTRIDIUM DIFFICILE COLITIS 88 0.0083
545 INCORRECT PRODUCT STORAGE 109 0.0083
546 MUSCLE SPASMS 1520 0.0083
547 HERNIA 160 0.0083
548 BACTERAEMIA 98 0.0082
549 URINARY RETENTION 274 0.0082
550 TRANSFUSION 86 0.0082
551 OXYGEN SATURATION DECREASED 461 0.0082
552 SPINAL PAIN 96 0.0082
553 FEELING ABNORMAL 1960 0.0082
554 DRY THROAT 83 0.0082
555 PRODUCTIVE COUGH 389 0.0081
556 EYE INFECTION 92 0.0081
557 MYOSITIS 73 0.0081
558 GASTRIC DISORDER 279 0.0081
559 BLINDNESS 331 0.0081
560 SKIN DISCOLOURATION 373 0.0081
561 BLOOD COUNT ABNORMAL 123 0.0081
562 PLATELET COUNT DECREASED 864 0.0081
563 COUGH 2273 0.0081
564 HYPOKINESIA 117 0.0081
565 RED BLOOD CELL SEDIMENTATION RATE INCREASED 89 0.0080
566 DEPRESSION 1827 0.0080
567 DEMENTIA 224 0.0080
568 TOOTHACHE 145 0.0080
569 DRUG ADMINISTRATION ERROR 245 0.0080
570 BLOOD CALCIUM INCREASED 70 0.0080
571 SKIN HAEMORRHAGE 118 0.0080
572 HYPOAESTHESIA ORAL 120 0.0080
573 UNEVALUABLE EVENT 602 0.0079
574 THROMBOSIS 640 0.0079
575 ENCEPHALOPATHY 195 0.0079
576 SINUS CONGESTION 107 0.0079
577 CYST 98 0.0079
578 FEEDING DISORDER 160 0.0079
579 PULMONARY THROMBOSIS 86 0.0079
580 LABORATORY TEST ABNORMAL 232 0.0079
581 BURNING SENSATION 551 0.0078
582 LIMB DISCOMFORT 243 0.0078
583 BLOOD ALKALINE PHOSPHATASE INCREASED 195 0.0078
584 INSOMNIA 2089 0.0078
585 ROAD TRAFFIC ACCIDENT 328 0.0078
586 VITAMIN D DECREASED 67 0.0078
587 DEEP VEIN THROMBOSIS 509 0.0078
588 BLOOD PRESSURE FLUCTUATION 188 0.0078
589 MEMORY IMPAIRMENT 1075 0.0078
590 RESPIRATORY DISTRESS 215 0.0078
591 RESPIRATORY DISORDER 233 0.0078
592 SCAR 133 0.0078
593 PULMONARY FIBROSIS 149 0.0078
594 MIDDLE INSOMNIA 145 0.0078
595 RASH GENERALISED 201 0.0078
596 FATIGUE 6034 0.0077
597 DYSPHAGIA 735 0.0077
598 INJECTION SITE PAIN 2370 0.0077
599 NASAL CONGESTION 454 0.0077
600 SCAB 88 0.0077
601 AMNESIA 501 0.0077
602 OESOPHAGITIS 84 0.0077
603 PNEUMONIA ASPIRATION 192 0.0077
604 SWOLLEN TONGUE 239 0.0076
605 BLOOD PRESSURE ABNORMAL 152 0.0076
606 ASPARTATE AMINOTRANSFERASE INCREASED 406 0.0076
607 VISUAL IMPAIRMENT 947 0.0076
608 CHEST DISCOMFORT 782 0.0076
609 POOR QUALITY SLEEP 164 0.0076
610 SPINAL DISORDER 72 0.0076
611 MYALGIA 1287 0.0076
612 SOMNOLENCE 1523 0.0076
613 HYPOAESTHESIA 1131 0.0075
614 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 537 0.0075
615 SPEECH DISORDER 395 0.0075
616 INJECTION SITE PRURITUS 505 0.0075
617 PANCYTOPENIA 421 0.0075
618 PHARYNGITIS 93 0.0075
619 HOT FLUSH 564 0.0075
620 EYE DISORDER 246 0.0075
621 CHILLS 874 0.0074
622 ANXIETY 2117 0.0074
623 INTENTIONAL PRODUCT MISUSE 649 0.0074
624 DENTAL CARIES 82 0.0074
625 INTESTINAL OBSTRUCTION 279 0.0074
626 SINUSITIS 756 0.0074
627 SUDDEN DEATH 78 0.0074
628 HYPERCALCAEMIA 91 0.0074
629 PARAESTHESIA ORAL 106 0.0073
630 INCORRECT DOSE ADMINISTERED 1676 0.0073
631 PRESCRIBED OVERDOSE 142 0.0073
632 WOUND 205 0.0073
633 THERAPEUTIC RESPONSE UNEXPECTED 329 0.0073
634 IMPAIRED DRIVING ABILITY 83 0.0073
635 BACTERIAL INFECTION 136 0.0073
636 PRODUCT QUALITY ISSUE 989 0.0073
637 DIPLOPIA 189 0.0073
638 CONVULSION 416 0.0073
639 SNEEZING 163 0.0073
640 PALPITATIONS 850 0.0073
641 IMPAIRED QUALITY OF LIFE 104 0.0072
642 DEPRESSED LEVEL OF CONSCIOUSNESS 286 0.0072
643 LIVER FUNCTION TEST ABNORMAL 210 0.0072
644 RESPIRATORY ARREST 199 0.0072
645 EAR INFECTION 192 0.0072
646 EYE PAIN 407 0.0072
647 INFLUENZA 798 0.0071
648 VERTIGO 436 0.0071
649 POST PROCEDURAL HAEMORRHAGE 83 0.0071
650 SKIN LESION 195 0.0071
651 WRIST FRACTURE 85 0.0071
652 GASTROINTESTINAL PAIN 78 0.0071
653 HAEMATOCHEZIA 390 0.0071
654 SWELLING 661 0.0071
655 ASPIRATION 77 0.0070
656 ARTHROPATHY 390 0.0070
657 SQUAMOUS CELL CARCINOMA 66 0.0070
658 ATAXIA 83 0.0070
659 ULCER 111 0.0070
660 COMA 331 0.0069
661 SPINAL FRACTURE 139 0.0069
662 MALAISE 3041 0.0069
663 WHEEZING 411 0.0069
664 EAR DISCOMFORT 71 0.0069
665 ORAL DISCOMFORT 96 0.0069
666 HIP FRACTURE 222 0.0069
667 TASTE DISORDER 139 0.0068
668 NEURALGIA 166 0.0068
669 CEREBRAL HAEMORRHAGE 244 0.0068
670 EXPIRED PRODUCT ADMINISTERED 225 0.0068
671 BURSITIS 82 0.0068
672 BREAST PAIN 72 0.0067
673 PLATELET COUNT INCREASED 88 0.0067
674 JOINT SWELLING 813 0.0067
675 MUSCULOSKELETAL DISORDER 128 0.0067
676 DRUG PRESCRIBING ERROR 129 0.0067
677 JOINT RANGE OF MOTION DECREASED 90 0.0067
678 OROPHARYNGEAL PAIN 620 0.0067
679 NASOPHARYNGITIS 1232 0.0067
680 IMPAIRED HEALING 219 0.0067
681 KNEE ARTHROPLASTY 140 0.0066
682 ABSCESS 106 0.0066
683 BEDRIDDEN 87 0.0066
684 PAIN 4057 0.0066
685 COORDINATION ABNORMAL 92 0.0066
686 PARAESTHESIA 1035 0.0066
687 MOVEMENT DISORDER 211 0.0066
688 OSTEOPOROSIS 270 0.0066
689 INJECTION SITE DISCOLOURATION 82 0.0066
690 NO THERAPEUTIC RESPONSE 80 0.0066
691 PRURITUS 2521 0.0066
692 NIGHT SWEATS 211 0.0065
693 INITIAL INSOMNIA 67 0.0065
694 SWELLING FACE 424 0.0065
695 MUSCLE TIGHTNESS 105 0.0065
696 CIRCULATORY COLLAPSE 110 0.0065
697 LIP SWELLING 215 0.0064
698 HALLUCINATION 486 0.0064
699 THINKING ABNORMAL 120 0.0064
700 DEVICE LEAKAGE 279 0.0064
701 WHITE BLOOD CELL COUNT DECREASED 697 0.0064
702 MYELODYSPLASTIC SYNDROME 93 0.0064
703 ARTHRALGIA 2672 0.0064
704 DEAFNESS 168 0.0064
705 MALIGNANT MELANOMA 86 0.0064
706 ABDOMINAL PAIN LOWER 162 0.0064
707 JOINT STIFFNESS 168 0.0064
708 PRODUCT ODOUR ABNORMAL 67 0.0064
709 LACRIMATION INCREASED 193 0.0064
710 LIVER DISORDER 283 0.0064
711 DELUSION 99 0.0064
712 HYPERBILIRUBINAEMIA 66 0.0064
713 BLOOD TEST ABNORMAL 89 0.0063
714 HEADACHE 3970 0.0063
715 INTENTIONAL DRUG MISUSE 132 0.0063
716 ABNORMAL DREAMS 174 0.0063
717 TOOTH DISORDER 140 0.0063
718 JAUNDICE 169 0.0063
719 INJECTION SITE URTICARIA 154 0.0063
720 ACUTE RESPIRATORY DISTRESS SYNDROME 111 0.0063
721 COVID-19 PNEUMONIA 74 0.0063
722 APHASIA 189 0.0063
723 HEPATIC FAILURE 188 0.0062
724 HEPATIC ENZYME INCREASED 424 0.0062
725 PULMONARY EMBOLISM 591 0.0062
726 EYE SWELLING 231 0.0062
727 CHOKING 121 0.0062
728 MOBILITY DECREASED 445 0.0062
729 HYPOCALCAEMIA 117 0.0062
730 INTRAOCULAR PRESSURE INCREASED 79 0.0062
731 BODY TEMPERATURE INCREASED 126 0.0062
732 DRUG EFFECT INCOMPLETE 224 0.0062
733 GLOSSODYNIA 138 0.0062
734 SEPTIC SHOCK 267 0.0061
735 INJECTION SITE RASH 188 0.0061
736 TINNITUS 281 0.0061
737 TOXICITY TO VARIOUS AGENTS 1030 0.0061
738 ALANINE AMINOTRANSFERASE INCREASED 375 0.0061
739 THROAT IRRITATION 273 0.0061
740 GASTRIC HAEMORRHAGE 70 0.0061
741 PARALYSIS 87 0.0061
742 PAIN IN JAW 172 0.0061
743 STOMATITIS 368 0.0061
744 PALLOR 165 0.0061
745 ANGIOEDEMA 268 0.0061
746 LOWER LIMB FRACTURE 116 0.0060
747 RASH MACULAR 211 0.0060
748 IMPAIRED WORK ABILITY 129 0.0060
749 TOOTH EXTRACTION 75 0.0060
750 HYPERTENSIVE CRISIS 67 0.0060
751 SKIN DISORDER 200 0.0060
752 LUNG DISORDER 293 0.0060
753 INTERSTITIAL LUNG DISEASE 289 0.0060
754 LYMPHADENOPATHY 210 0.0059
755 BLOOD LACTATE DEHYDROGENASE INCREASED 94 0.0059
756 GINGIVAL BLEEDING 81 0.0059
757 FIBROMYALGIA 144 0.0059
758 SLEEP DISORDER 418 0.0059
759 NEEDLE ISSUE 172 0.0059
760 PHOTOPHOBIA 110 0.0058
761 APHONIA 81 0.0058
762 ACCIDENT 69 0.0058
763 MUSCLE RIGIDITY 69 0.0058
764 THERAPY CESSATION 296 0.0058
765 ALOPECIA 1128 0.0057
766 EXTRA DOSE ADMINISTERED 232 0.0057
767 METASTASES TO BONE 94 0.0057
768 HALLUCINATION, AUDITORY 91 0.0057
769 EOSINOPHILIA 100 0.0057
770 DERMATITIS CONTACT 65 0.0057
771 THROAT TIGHTNESS 154 0.0057
772 MENTAL IMPAIRMENT 138 0.0057
773 INCORRECT DRUG ADMINISTRATION DURATION 160 0.0057
774 GAIT INABILITY 190 0.0057
775 PLASMA CELL MYELOMA 221 0.0057
776 BONE PAIN 330 0.0056
777 LYMPHOMA 87 0.0056
778 HERPES ZOSTER 323 0.0056
779 SENSORY DISTURBANCE 90 0.0056
780 GAMMA-GLUTAMYLTRANSFERASE INCREASED 124 0.0056
781 PULMONARY ARTERIAL HYPERTENSION 81 0.0056
782 EMOTIONAL DISTRESS 674 0.0056
783 AGITATION 408 0.0055
784 EMOTIONAL DISORDER 171 0.0055
785 SKIN CANCER 119 0.0055
786 SPINAL OPERATION 68 0.0055
787 BLOOD BILIRUBIN INCREASED 149 0.0055
788 DYSKINESIA 224 0.0055
789 PARANOIA 95 0.0055
790 IRRITABILITY 331 0.0055
791 VIRAL INFECTION 183 0.0055
792 INCORRECT DOSE ADMINISTERED BY DEVICE 144 0.0055
793 POISONING 69 0.0055
794 RASH 2393 0.0055
795 ASTHMA 620 0.0055
796 IRRITABLE BOWEL SYNDROME 117 0.0055
797 PSORIASIS 712 0.0054
798 MULTIPLE ORGAN DYSFUNCTION SYNDROME 154 0.0054
799 THROMBOCYTOPENIA 607 0.0054
800 ACUTE HEPATIC FAILURE 74 0.0054
801 DISSEMINATED INTRAVASCULAR COAGULATION 76 0.0054
802 DEVICE FAILURE 82 0.0054
803 BRAIN OEDEMA 68 0.0054
804 RESTLESSNESS 197 0.0054
805 MUSCLE TWITCHING 124 0.0054
806 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 125 0.0054
807 TENDONITIS 83 0.0054
808 DISABILITY 106 0.0054
809 ADRENAL INSUFFICIENCY 65 0.0054
810 HEPATITIS 136 0.0053
811 CLOSTRIDIUM DIFFICILE INFECTION 116 0.0053
812 HAEMORRHAGE 555 0.0053
813 PHOTOSENSITIVITY REACTION 87 0.0053
814 DRUG INEFFECTIVE 6931 0.0053
815 MUSCULOSKELETAL STIFFNESS 459 0.0052
816 INFECTION 756 0.0052
817 LUNG INFECTION 81 0.0052
818 DERMATITIS 109 0.0052
819 INTENTIONAL OVERDOSE 333 0.0052
820 RASH PAPULAR 116 0.0052
821 CONDITION AGGRAVATED 1573 0.0052
822 MENTAL DISORDER 225 0.0052
823 PRODUCT TASTE ABNORMAL 70 0.0052
824 FEMUR FRACTURE 160 0.0052
825 HEPATOTOXICITY 115 0.0052
826 PANIC ATTACK 188 0.0052
827 DEVICE MALFUNCTION 361 0.0051
828 PYREXIA 1765 0.0051
829 INJECTION SITE INDURATION 66 0.0051
830 NIGHTMARE 176 0.0051
831 DELIRIUM 176 0.0051
832 ANGER 171 0.0051
833 PROCEDURAL PAIN 140 0.0050
834 URTICARIA 845 0.0050
835 HEPATIC FUNCTION ABNORMAL 188 0.0050
836 ILL-DEFINED DISORDER 305 0.0050
837 GASTROINTESTINAL DISORDER 449 0.0050
838 INJURY ASSOCIATED WITH DEVICE 102 0.0050
839 STEVENS-JOHNSON SYNDROME 111 0.0050
840 PNEUMOTHORAX 79 0.0050
841 OCULAR HYPERAEMIA 236 0.0050
842 DISEASE PROGRESSION 587 0.0050
843 FREQUENT BOWEL MOVEMENTS 134 0.0050
844 CONJUNCTIVITIS 92 0.0050
845 GENERAL PHYSICAL HEALTH DETERIORATION 573 0.0049
846 DISCOMFORT 301 0.0049
847 PRODUCT PHYSICAL ISSUE 99 0.0049
848 INSURANCE ISSUE 75 0.0049
849 HIP ARTHROPLASTY 75 0.0049
850 DISTURBANCE IN ATTENTION 262 0.0049
851 CANDIDA INFECTION 82 0.0049
852 ANAPHYLACTIC REACTION 268 0.0048
853 LIVER INJURY 119 0.0048
854 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 231 0.0048
855 TARDIVE DYSKINESIA 134 0.0047
856 DRUG ERUPTION 84 0.0047
857 CHOLESTASIS 91 0.0047
858 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 260 0.0047
859 DEPRESSED MOOD 249 0.0047
860 COGNITIVE DISORDER 219 0.0047
861 INFLUENZA LIKE ILLNESS 386 0.0047
862 DRUG INTOLERANCE 452 0.0047
863 ERYTHEMA 961 0.0047
864 SURGERY 273 0.0047
865 MOUTH ULCERATION 98 0.0046
866 OSTEONECROSIS OF JAW 115 0.0046
867 ABNORMAL BEHAVIOUR 184 0.0046
868 EYE PRURITUS 156 0.0046
869 RESPIRATORY TRACT INFECTION 120 0.0046
870 TACHYCARDIA 408 0.0046
871 DRY EYE 229 0.0046
872 MUCOSAL INFLAMMATION 120 0.0046
873 DEVICE ISSUE 411 0.0046
874 HEAD DISCOMFORT 81 0.0046
875 HYPERSENSITIVITY 848 0.0046
876 FRACTURE 86 0.0045
877 SKIN EXFOLIATION 383 0.0045
878 INJECTION SITE ERYTHEMA 562 0.0045
879 NEOPLASM MALIGNANT 302 0.0045
880 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 211 0.0045
881 EXTRAPYRAMIDAL DISORDER 111 0.0045
882 EYE IRRITATION 257 0.0045
883 INTENTIONAL DOSE OMISSION 126 0.0044
884 DEVICE RELATED INFECTION 68 0.0044
885 CRYING 160 0.0044
886 PRODUCT USE ISSUE 827 0.0044
887 FACE OEDEMA 74 0.0044
888 PNEUMONITIS 119 0.0044
889 PRODUCT DOSE OMISSION ISSUE 1285 0.0044
890 TRANSAMINASES INCREASED 97 0.0044
891 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 785 0.0044
892 COLITIS 165 0.0043
893 SKIN FISSURES 84 0.0043
894 TOOTH LOSS 89 0.0043
895 THERAPEUTIC RESPONSE DECREASED 260 0.0043
896 LIVER FUNCTION TEST INCREASED 92 0.0043
897 INFLAMMATION 220 0.0043
898 CYANOSIS 67 0.0043
899 DRUG-INDUCED LIVER INJURY 133 0.0042
900 DEATH 3630 0.0042
901 THERAPY INTERRUPTED 301 0.0042
902 SUICIDE ATTEMPT 255 0.0042
903 NEUTROPHIL COUNT DECREASED 171 0.0042
904 PSORIATIC ARTHROPATHY 169 0.0042
905 LUNG NEOPLASM MALIGNANT 171 0.0042
906 MANIA 68 0.0041
907 NERVOUS SYSTEM DISORDER 129 0.0041
908 THERAPY NON-RESPONDER 185 0.0041
909 ELECTROCARDIOGRAM QT PROLONGED 148 0.0041
910 INTENTIONAL PRODUCT USE ISSUE 360 0.0041
911 PERICARDITIS 69 0.0041
912 ILLNESS 420 0.0041
913 INJECTION SITE SWELLING 311 0.0041
914 ADVERSE DRUG REACTION 364 0.0040
915 PRODUCT SUBSTITUTION ISSUE 233 0.0040
916 RASH ERYTHEMATOUS 193 0.0040
917 COVID-19 705 0.0040
918 MULTIPLE FRACTURES 66 0.0040
919 SUICIDAL IDEATION 367 0.0040
920 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 135 0.0040
921 ADVERSE EVENT 368 0.0040
922 MOOD SWINGS 127 0.0040
923 MALIGNANT NEOPLASM PROGRESSION 408 0.0040
924 FEBRILE NEUTROPENIA 264 0.0040
925 DRY SKIN 531 0.0040
926 C-REACTIVE PROTEIN INCREASED 144 0.0040
927 PRODUCT DOSE OMISSION IN ERROR 112 0.0040
928 NEOPLASM PROGRESSION 137 0.0039
929 MOOD ALTERED 104 0.0038
930 PRESCRIBED UNDERDOSE 76 0.0038
931 PSYCHOTIC DISORDER 112 0.0038
932 BONE MARROW FAILURE 77 0.0038
933 PRODUCT DISPENSING ERROR 82 0.0038
934 OFF LABEL USE 3274 0.0037
935 LYMPHOCYTE COUNT DECREASED 66 0.0037
936 RHEUMATOID ARTHRITIS 423 0.0037
937 HOSPITALISATION 569 0.0037
938 PRODUCT ADMINISTRATION ERROR 74 0.0037
939 AGGRESSION 181 0.0036
940 APPLICATION SITE PAIN 79 0.0036
941 INFUSION RELATED REACTION 237 0.0036
942 PRODUCT PRESCRIBING ERROR 85 0.0036
943 RASH MACULO-PAPULAR 79 0.0035
944 ORAL HERPES 69 0.0035
945 SEDATION 92 0.0035
946 PAIN OF SKIN 94 0.0035
947 PRODUCT AVAILABILITY ISSUE 79 0.0035
948 INJECTION SITE WARMTH 71 0.0034
949 NEUTROPENIA 468 0.0034
950 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 689 0.0034
951 OVERDOSE 725 0.0034
952 BREAST CANCER FEMALE 88 0.0033
953 LEUKOPENIA 164 0.0033
954 INCORRECT PRODUCT ADMINISTRATION DURATION 71 0.0033
955 SEIZURE 373 0.0032
956 MIGRAINE 304 0.0032
957 BONE DENSITY DECREASED 99 0.0032
958 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 222 0.0031
959 INJECTION SITE REACTION 210 0.0030
960 CONTRAINDICATED PRODUCT ADMINISTERED 92 0.0030
961 VAGINAL HAEMORRHAGE 129 0.0030
962 OSTEONECROSIS 94 0.0029
963 WITHDRAWAL SYNDROME 120 0.0029
964 APPLICATION SITE ERYTHEMA 73 0.0028
965 ECZEMA 144 0.0027
966 GASTRIC CANCER 68 0.0027
967 THERAPEUTIC PRODUCT EFFECT DECREASED 120 0.0027
968 ANAPHYLACTIC SHOCK 69 0.0027
969 PRODUCT USE IN UNAPPROVED INDICATION 648 0.0026
970 DISEASE RECURRENCE 122 0.0026
971 PRODUCT STORAGE ERROR 224 0.0026
972 SKIN BURNING SENSATION 182 0.0025
973 PROSTATE CANCER 200 0.0025
974 DEVICE DELIVERY SYSTEM ISSUE 67 0.0024
975 PRODUCT ADHESION ISSUE 79 0.0022
976 BREAST CANCER 205 0.0022
977 RENAL CANCER 104 0.0022
978 SKIN IRRITATION 96 0.0021
979 MULTIPLE SCLEROSIS RELAPSE 143 0.0021
980 LOWER RESPIRATORY TRACT INFECTION 91 0.0020
981 THERAPEUTIC RESPONSE SHORTENED 66 0.0020
982 TREATMENT FAILURE 162 0.0020
983 SYSTEMIC LUPUS ERYTHEMATOSUS 69 0.0019
984 MULTIPLE SCLEROSIS 90 0.0019
985 DRUG WITHDRAWAL SYNDROME 165 0.0019
986 NO ADVERSE EVENT 329 0.0018
987 ACCIDENTAL EXPOSURE TO PRODUCT 187 0.0018
988 COLITIS ULCERATIVE 80 0.0018
989 DERMATITIS ATOPIC 86 0.0016
990 ACNE 123 0.0016
991 DRUG ABUSE 88 0.0011
992 DRUG DOSE OMISSION BY DEVICE 74 0.0009
993 DRUG DEPENDENCE 130 0.0008